Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 116
Filter
Add more filters

Publication year range
1.
N Engl J Med ; 389(25): 2355-2362, 2023 Dec 21.
Article in English | MEDLINE | ID: mdl-38118023

ABSTRACT

Melioidosis, caused by Burkholderia pseudomallei, is a rare but potentially fatal bacterial disease endemic to tropical and subtropical regions worldwide. It is typically acquired through contact with contaminated soil or fresh water. Before this investigation, B. pseudomallei was not known to have been isolated from the environment in the continental United States. Here, we report on three patients living in the same Mississippi Gulf Coast county who presented with melioidosis within a 3-year period. They were infected by the same Western Hemisphere B. pseudomallei strain that was discovered in three environmental samples collected from the property of one of the patients. These findings indicate local acquisition of melioidosis from the environment in the Mississippi Gulf Coast region.


Subject(s)
Burkholderia pseudomallei , Environmental Microbiology , Melioidosis , Humans , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/isolation & purification , Melioidosis/epidemiology , Melioidosis/microbiology , United States/epidemiology
2.
N Engl J Med ; 386(9): 861-868, 2022 03 03.
Article in English | MEDLINE | ID: mdl-35235727

ABSTRACT

Melioidosis, caused by the bacterium Burkholderia pseudomallei, is an uncommon infection that is typically associated with exposure to soil and water in tropical and subtropical environments. It is rarely diagnosed in the continental United States. Patients with melioidosis in the United States commonly report travel to regions where melioidosis is endemic. We report a cluster of four non-travel-associated cases of melioidosis in Georgia, Kansas, Minnesota, and Texas. These cases were caused by the same strain of B. pseudomallei that was linked to an aromatherapy spray product imported from a melioidosis-endemic area.


Subject(s)
Aromatherapy/adverse effects , Burkholderia pseudomallei/isolation & purification , Disease Outbreaks , Melioidosis/epidemiology , Aerosols , Brain/microbiology , Brain/pathology , Burkholderia pseudomallei/genetics , COVID-19/complications , Child, Preschool , Fatal Outcome , Female , Genome, Bacterial , Humans , Lung/microbiology , Lung/pathology , Male , Melioidosis/complications , Middle Aged , Phylogeny , Shock, Septic/microbiology , United States/epidemiology
3.
PLoS Pathog ; 18(12): e1010735, 2022 12.
Article in English | MEDLINE | ID: mdl-36534695

ABSTRACT

Inhalation anthrax has three clinical stages: early-prodromal, intermediate-progressive, and late-fulminant. We report the comprehensive characterization of anthrax toxins, including total protective antigen (PA), total lethal factor (LF), total edema factor (EF), and their toxin complexes, lethal toxin and edema toxin in plasma, during the course of inhalation anthrax in 23 cynomolgus macaques. The toxin kinetics were predominantly triphasic with an early rise (phase-1), a plateau/decline (phase-2), and a final rapid rise (phase-3). Eleven animals had shorter survival times, mean±standard deviation of 58.7±7.6 hours (fast progression), 11 animals had longer survival times, 113±34.4 hours (slow progression), and one animal survived. Median (lower-upper quartile) LF levels at the end-of-phase-1 were significantly higher in animals with fast progression [138 (54.9-326) ng/mL], than in those with slow progression [23.8 (15.6-26.3) ng/mL] (p = 0.0002), and the survivor (11.1 ng/mL). The differences were also observed for other toxins and bacteremia. Animals with slow progression had an extended phase-2 plateau, with low variability of LF levels across all time points and animals. Characterization of phase-2 toxin levels defined upper thresholds; critical levels for exiting phase-2 and entering the critical phase-3, 342 ng/mL (PA), 35.8 ng/mL (LF), and 1.10 ng/mL (EF). The thresholds were exceeded earlier in animals with fast progression (38.5±7.4 hours) and later in animals with slow progression (78.7±15.2 hours). Once the threshold was passed, toxin levels rose rapidly in both groups to the terminal stage. The time from threshold to terminal was rapid and similar; 20.8±7.4 hours for fast and 19.9±7.5 hours for slow progression. The three toxemic phases were aligned with the three clinical stages of anthrax for fast and slow progression which showed that anthrax progression is toxin- rather than time-dependent. This first comprehensive evaluation of anthrax toxins provides new insights into disease progression.


Subject(s)
Anthrax , Bacillus anthracis , Respiratory Tract Infections , Animals , Antigens, Bacterial , Macaca mulatta
4.
Emerg Infect Dis ; 29(3): 618-621, 2023 03.
Article in English | MEDLINE | ID: mdl-36823515

ABSTRACT

Burkholderia thailandensis, an opportunistic pathogen found in the environment, is a bacterium closely related to B. pseudomallei, the cause of melioidosis. Human B. thailandensis infections are uncommon. We isolated B. thailandensis from water in Texas and Puerto Rico and soil in Mississippi in the United States, demonstrating a potential public health risk.


Subject(s)
Burkholderia Infections , Burkholderia pseudomallei , Burkholderia , Melioidosis , United States , Humans , Burkholderia Infections/microbiology
5.
Clin Infect Dis ; 75(Suppl 3): S354-S363, 2022 10 17.
Article in English | MEDLINE | ID: mdl-36251561

ABSTRACT

Bacillus anthracis has traditionally been considered the etiologic agent of anthrax. However, anthrax-like illness has been documented in welders and other metal workers infected with Bacillus cereus group spp. harboring pXO1 virulence genes that produce anthrax toxins. We present 2 recent cases of severe pneumonia in welders with B. cereus group infections and discuss potential risk factors for infection and treatment options, including antitoxin.


Subject(s)
Anthrax , Antitoxins , Bacillus anthracis , Anthrax/diagnosis , Anthrax/drug therapy , Bacillus anthracis/genetics , Bacillus cereus/genetics , Humans , Metal Workers , Plasmids
6.
Emerg Infect Dis ; 27(12): 3030-3035, 2021 12.
Article in English | MEDLINE | ID: mdl-34570693

ABSTRACT

Nearly all cases of melioidosis in the continental United States are related to international travel to areas to which Burkholderia pseudomallei, the bacterium that causes melioidosis, is endemic. We report the diagnosis and clinical course of melioidosis in a patient from the United States who had no international travel history and the public health investigation to determine the source of exposure. We tested environmental samples collected from the patient's home for B. pseudomallei by PCR and culture. Whole-genome sequencing was conducted on PCR-positive environmental samples, and results were compared with sequences from the patient's clinical specimen. Three PCR-positive environmental samples, all collected from a freshwater home aquarium that had contained imported tropical fish, were a genetic match to the clinical isolate from the patient. This finding suggests a novel route of exposure and a potential for importation of B. pseudomallei, a select agent, into the United States from disease-endemic areas.


Subject(s)
Burkholderia pseudomallei , Melioidosis , Animals , Burkholderia pseudomallei/genetics , Fresh Water , Humans , Melioidosis/diagnosis , Melioidosis/epidemiology , Polymerase Chain Reaction , United States/epidemiology , Whole Genome Sequencing
7.
Emerg Infect Dis ; 26(11): 2773-2775, 2020 11.
Article in English | MEDLINE | ID: mdl-33079041

ABSTRACT

The distribution of Burkholderia pseudomallei in the Caribbean is poorly understood. We isolated B. pseudomallei from US Virgin Islands soil. The soil isolate was genetically similar to other isolates from the Caribbean, suggesting that B. pseudomallei might have been introduced to the islands multiple times through severe weather events.


Subject(s)
Burkholderia pseudomallei , Melioidosis , Soil Microbiology , Burkholderia pseudomallei/genetics , Humans , Islands , Melioidosis/epidemiology , Phylogeny , United States Virgin Islands
8.
Emerg Infect Dis ; 26(2): 358-361, 2020 02.
Article in English | MEDLINE | ID: mdl-31961318

ABSTRACT

Human anthrax cases necessitate rapid response. We completed Bacillus anthracis nanopore whole-genome sequencing in our high-containment laboratory from a human anthrax isolate hours after receipt. The de novo assembled genome showed no evidence of known antimicrobial resistance genes or introduced plasmid(s). Same-day genomic characterization enhances public health emergency response.


Subject(s)
Anthrax/prevention & control , Bacillus anthracis/isolation & purification , Bacillus anthracis/genetics , Bioterrorism , Civil Defense , Genome, Bacterial , Humans , Public Health , Real-Time Polymerase Chain Reaction , United States , Whole Genome Sequencing
9.
Emerg Infect Dis ; 26(6): 1295-1299, 2020 06.
Article in English | MEDLINE | ID: mdl-32442394

ABSTRACT

To our knowledge, environmental isolation of Burkholderia pseudomallei, the causative agent of melioidosis, from the continental United States has not been reported. We report a case of melioidosis in a Texas resident. Genomic analysis indicated that the isolate groups with B. pseudomallei isolates from patients in the same region, suggesting possible endemicity to this region.


Subject(s)
Burkholderia pseudomallei , Melioidosis , Burkholderia pseudomallei/genetics , Genomics , Humans , Melioidosis/diagnosis , Texas/epidemiology , Travel , United States
10.
J Clin Microbiol ; 58(2)2020 01 28.
Article in English | MEDLINE | ID: mdl-31694974

ABSTRACT

From 2015 to 2017, 11 confirmed brucellosis cases were reported in New York City, leading to 10 Brucella exposure risk events (Brucella events) in 7 clinical laboratories (CLs). Most patients had traveled to countries where brucellosis is endemic and presented with histories and findings consistent with brucellosis. CLs were not notified that specimens might yield a hazardous organism, as the clinicians did not consider brucellosis until they were notified that bacteremia with Brucella was suspected. In 3 Brucella events, the CLs did not suspect that slow-growing, small Gram-negative bacteria might be harmful. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), which has a limited capacity to identify biological threat agents (BTAs), was used during 4 Brucella events, which accounted for 84% of exposures. In 3 of these incidents, initial staining of liquid media showed Gram-positive rods or cocci, including some cocci in chains, suggesting streptococci. Over 200 occupational exposures occurred when the unknown isolates were manipulated and/or tested on open benches, including by procedures that could generate infectious aerosols. During 3 Brucella events, the CLs examined and/or manipulated isolates in a biological safety cabinet (BSC); in each CL, the CL had previously isolated Brucella Centers for Disease Control and Prevention recommendations to prevent laboratory-acquired brucellosis (LAB) were followed; no seroconversions or LAB cases occurred. Laboratory assessments were conducted after the Brucella events to identify facility-specific risks and mitigations. With increasing MALDI-TOF MS use, CLs are well-advised to adhere strictly to safe work practices, such as handling and manipulating all slow-growing organisms in BSCs and not using MALDI-TOF MS for identification until BTAs have been ruled out.


Subject(s)
Brucella/isolation & purification , Brucellosis/diagnosis , Clinical Laboratory Techniques/standards , Laboratory Infection/microbiology , Occupational Exposure/statistics & numerical data , Brucella/growth & development , Brucellosis/etiology , Colony Count, Microbial , Humans , New York City , Occupational Exposure/prevention & control , Risk Factors , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
11.
Emerg Infect Dis ; 25(10): 1952-1955, 2019 10.
Article in English | MEDLINE | ID: mdl-31538918

ABSTRACT

We report 2 cases of melioidosis in women with diabetes admitted to an emergency department in the US Virgin Islands during October 2017. These cases emerged after Hurricanes Irma and Maria and did not have a definitively identified source. Poor outcomes were observed when septicemia and pulmonary involvement were present.


Subject(s)
Cyclonic Storms , Melioidosis/epidemiology , Natural Disasters , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Burkholderia pseudomallei/drug effects , Female , Humans , Melioidosis/diagnosis , Melioidosis/drug therapy , Microbial Sensitivity Tests , Middle Aged , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , United States Virgin Islands/epidemiology
12.
Emerg Infect Dis ; 25(5): 947-950, 2019 05.
Article in English | MEDLINE | ID: mdl-31002072

ABSTRACT

In late September 2017, Bwabwata National Park in Namibia experienced a sudden die-off of hippopotamuses and Cape buffalo. A multiorganizational response was initiated, involving several ministries within Namibia and the US Centers for Disease Control and Prevention. Rapid interventions resulted in zero human or livestock cases associated with this epizootic.


Subject(s)
Animal Diseases/epidemiology , Animal Diseases/microbiology , Animals, Wild , Anthrax/epidemiology , Anthrax/microbiology , Bacillus anthracis , Parks, Recreational , Animal Diseases/history , Animals , Anthrax/history , Geography , History, 21st Century , Humans , Namibia/epidemiology
14.
Anal Bioanal Chem ; 411(12): 2493-2509, 2019 May.
Article in English | MEDLINE | ID: mdl-30911800

ABSTRACT

Inhalation of Bacillus anthracis spores can cause a rapidly progressing fatal infection. B. anthracis secretes three protein toxins: lethal factor (LF), edema factor (EF), and protective antigen (PA). EF and LF may circulate as free or PA-bound forms. Both free EF (EF) and PA-bound-EF (ETx) have adenylyl cyclase activity converting ATP to cAMP. We developed an adenylyl cyclase activity-based method for detecting and quantifying total EF (EF+ETx) in plasma. The three-step method includes magnetic immunocapture with monoclonal antibodies, reaction with ATP generating cAMP, and quantification of cAMP by isotope-dilution HPLC-MS/MS. Total EF was quantified from 5PL regression of cAMP vs ETx concentration. The detection limit was 20 fg/mL (225 zeptomoles/mL for the 89 kDa protein). Relative standard deviations for controls with 0.3, 6.0, and 90 pg/mL were 11.7-16.6% with 91.2-99.5% accuracy. The method demonstrated 100% specificity in 238 human serum/plasma samples collected from unexposed healthy individuals, and 100% sensitivity in samples from 3 human and 5 rhesus macaques with inhalation anthrax. Analysis of EF in the rhesus macaques showed that it was detected earlier post-exposure than B. anthracis by culture and PCR. Similar to LF, the kinetics of EF over the course of infection were triphasic, with an initial rise (phase-1), decline (phase-2), and final rapid rise (phase-3). EF levels were ~ 2-4 orders of magnitude lower than LF during phase-1 and phase-2 and only ~ 6-fold lower at death/euthanasia. Analysis of EF improves early diagnosis and adds to our understanding of anthrax toxemia throughout infection. The LF/EF ratio may also indicate the stage of infection and need for advanced treatments.


Subject(s)
Anthrax/pathology , Antigens, Bacterial/blood , Bacillus anthracis/pathogenicity , Bacterial Toxins/blood , Chromatography, High Pressure Liquid/methods , Respiratory Tract Infections/pathology , Tandem Mass Spectrometry/methods , Toxemia/pathology , Adenosine Triphosphate/metabolism , Animals , Anthrax/blood , Case-Control Studies , Cyclic AMP/biosynthesis , Disease Progression , Enzyme-Linked Immunosorbent Assay , Humans , Limit of Detection , Macaca mulatta , Polymerase Chain Reaction , Respiratory Tract Infections/blood , Toxemia/blood , Toxemia/microbiology
15.
Emerg Infect Dis ; 24(11): 2091-2094, 2018 11.
Article in English | MEDLINE | ID: mdl-30334705

ABSTRACT

The bacterium Burkholderia thailandensis, a member of the Burkholderia pseudomallei complex, is generally considered nonpathogenic; however, on rare occasions, B. thailandensis infections have been reported. We describe a clinical isolate of B. thailandensis, BtAR2017, recovered from a patient with an infected wound in Arkansas, USA, in 2017.


Subject(s)
Burkholderia Infections/microbiology , Burkholderia/classification , Genome, Bacterial/genetics , Wound Infection/microbiology , Adult , Arkansas , Bacterial Typing Techniques , Burkholderia/genetics , Burkholderia Infections/diagnosis , Female , Humans , Multilocus Sequence Typing , Phylogeny , Wound Infection/diagnosis
16.
Anal Biochem ; 543: 97-107, 2018 02 15.
Article in English | MEDLINE | ID: mdl-29224733

ABSTRACT

Anthrax lethal factor (LF) is a zinc-dependent endoprotease and a critical virulence factor for Bacillus anthracis, the causative agent of anthrax. The mass spectrometry (MS) method for total-LF quantification includes three steps; 1) LF specific antibody capture/concentration, 2) LF-specific hydrolysis of a peptide substrate, and 3) detection and quantification of LF-cleaved peptides by isotope-dilution MALDI-TOF/MS. Recombinant LF spiked plasma was used for calibration and quality control (QC) materials. Specificity was 100% from analysis of serum and plasma from 383 non-infected humans, 31 rabbits, and 24 rhesus macaques. Sensitivity was 100% from 32 human clinical anthrax cases including infections by inhalation, ingestion, cutaneous and injection exposures and experimental infections for 29 rabbits and 24 rhesus macaques with inhalation anthrax. Robustness evaluation included sample storage, serum and plasma, antimicrobial and antitoxin effects and long-term performance. Data from 100 independent runs gave detection limits 0.01 ng/mL (111 amol/mL) for the 4-h method and 0.0027 ng/mL (30 amol/mL) for an alternate 20-h method. QC precision ranged from 7.7 to 14.8% coefficient of variation and accuracy from 0.2 to 9.8% error. The validated LF MS method provides sensitive quantification of anthrax total-LF using a robust high throughput platform for early diagnosis and evaluation of therapeutics during an anthrax emergency.


Subject(s)
Anthrax/diagnosis , Anthrax/drug therapy , Antigens, Bacterial/analysis , Bacillus anthracis/chemistry , Bacterial Toxins/analysis , Animals , Anti-Bacterial Agents/pharmacology , Bacillus anthracis/drug effects , Calibration , Humans , Macaca mulatta , Quality Control , Rabbits , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
18.
Emerg Infect Dis ; 23(7): 1133-1138, 2017 07.
Article in English | MEDLINE | ID: mdl-28628442

ABSTRACT

The bacterium Burkholderia pseudomallei causes melioidosis, which is mainly associated with tropical areas. We analyzed single-nucleotide polymorphisms (SNPs) among genome sequences from isolates of B. pseudomallei that originated in the Western Hemisphere by comparing them with genome sequences of isolates that originated in the Eastern Hemisphere. Analysis indicated that isolates from the Western Hemisphere form a distinct clade, which supports the hypothesis that these isolates were derived from a constricted seeding event from Africa. Subclades have been resolved that are associated with specific regions within the Western Hemisphere and suggest that isolates might be correlated geographically with cases of melioidosis. One isolate associated with a former World War II prisoner of war was believed to represent illness 62 years after exposure in Southeast Asia. However, analysis suggested the isolate originated in Central or South America.


Subject(s)
Burkholderia pseudomallei/classification , Burkholderia pseudomallei/genetics , Melioidosis/epidemiology , Melioidosis/microbiology , Phylogeny , Phylogeography , Burkholderia pseudomallei/isolation & purification , Genome, Bacterial , Genomics/methods , Global Health , Humans , Multilocus Sequence Typing , Polymorphism, Single Nucleotide
19.
Emerg Infect Dis ; 23(13)2017 12.
Article in English | MEDLINE | ID: mdl-29155651

ABSTRACT

Naturally occurring anthrax disproportionately affects the health and economic welfare of poor, rural communities in anthrax-endemic countries. However, many of these countries have limited anthrax prevention and control programs. Effective prevention of anthrax outbreaks among humans is accomplished through routine livestock vaccination programs and prompt response to animal outbreaks. The Centers for Disease Control and Prevention uses a 2-phase framework when providing technical assistance to partners in anthrax-endemic countries. The first phase assesses and identifies areas for improvement in existing human and animal surveillance, laboratory diagnostics, and outbreak response. The second phase provides steps to implement improvements to these areas. We describe examples of implementing this framework in anthrax-endemic countries. These activities are at varying stages of completion; however, the public health impact of these initiatives has been encouraging. The anthrax framework can be extended to other zoonotic diseases to build on these efforts, improve human and animal health, and enhance global health security.


Subject(s)
Anthrax/diagnosis , Anthrax/epidemiology , Bacillus anthracis , Public Health Surveillance , Anthrax/prevention & control , Anthrax/transmission , Capacity Building , Clinical Laboratory Techniques , Disease Outbreaks , Epidemics , Health Plan Implementation , Humans , Public Health Surveillance/methods , Vaccination
20.
Article in English | MEDLINE | ID: mdl-28396541

ABSTRACT

Burkholderia pseudomallei Bp1651 is resistant to several classes of antibiotics that are usually effective for treatment of melioidosis, including tetracyclines, sulfonamides, and ß-lactams such as penicillins (amoxicillin-clavulanic acid), cephalosporins (ceftazidime), and carbapenems (imipenem and meropenem). We sequenced, assembled, and annotated the Bp1651 genome and analyzed the sequence using comparative genomic analyses with susceptible strains, keyword searches of the annotation, publicly available antimicrobial resistance prediction tools, and published reports. More than 100 genes in the Bp1651 sequence were identified as potentially contributing to antimicrobial resistance. Most notably, we identified three previously uncharacterized point mutations in penA, which codes for a class A ß-lactamase and was previously implicated in resistance to ß-lactam antibiotics. The mutations result in amino acid changes T147A, D240G, and V261I. When individually introduced into select agent-excluded B. pseudomallei strain Bp82, D240G was found to contribute to ceftazidime resistance and T147A contributed to amoxicillin-clavulanic acid and imipenem resistance. This study provides the first evidence that mutations in penA may alter susceptibility to carbapenems in B. pseudomallei Another mutation of interest was a point mutation affecting the dihydrofolate reductase gene folA, which likely explains the trimethoprim resistance of this strain. Bp1651 was susceptible to aminoglycosides likely because of a frameshift in the amrB gene, the transporter subunit of the AmrAB-OprA efflux pump. These findings expand the role of penA to include resistance to carbapenems and may assist in the development of molecular diagnostics that predict antimicrobial resistance and provide guidance for treatment of melioidosis.


Subject(s)
Anti-Bacterial Agents/pharmacology , Burkholderia pseudomallei/drug effects , Burkholderia pseudomallei/genetics , Drug Resistance, Multiple, Bacterial/genetics , Imipenem/pharmacology , beta-Lactamases/genetics , Amoxicillin-Potassium Clavulanate Combination/pharmacology , Burkholderia pseudomallei/classification , Ceftazidime/pharmacology , Genome, Bacterial/genetics , Humans , Melioidosis/drug therapy , Melioidosis/microbiology , Membrane Transport Proteins/genetics , Microbial Sensitivity Tests , Sequence Analysis, DNA , Tetrahydrofolate Dehydrogenase/genetics , Trimethoprim/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL